AGER and lung carcinoma: The levels of serum sRAGE and tissue RAGE potentially could be an effective and convenient diagnostic biomarker for lung cancer, and the presence of RAGE polymorphism may aid the diagnosis of lung cancer and the clinical assessment of prognosis.